<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02967094</url>
  </required_header>
  <id_info>
    <org_study_id>DDC VN 09</org_study_id>
    <nct_id>NCT02967094</nct_id>
  </id_info>
  <brief_title>Mucolytic Solution Before Upper Endoscopy</brief_title>
  <official_title>The Use of Mucolytic Solution Before Upper Endoscopy: A Randomized, Double-blinded Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vitkovice Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vitkovice Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study was designed to evaluate efficacy of mucolytic solution ingested before upper endoscopy
      on visibility of gastric mucosa.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Residual gastric content containing mucus, bubbles, bile and food particles may limit
      visibility of gastric mucosa and therefore diagnostic yield of upper endoscopy, especially in
      cases of early neoplastic lesions. Data on benefit of peroral mucolytic solution administered
      before upper endoscopy are limited.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>&quot;Visibility score&quot; evaluated by blinded performing endoscopist</measure>
    <time_frame>through study completion, an average of 3 months</time_frame>
    <description>&quot;Visibility score&quot; (0-25 points) counted as the sum of visibility score in the esophagus (0-5), fundus (0-5), corpus (0-5) and atrum (0-5) of the stomach and in the duodenum (0-5).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>&quot;Visibility score&quot; evaluated by three blinded endoscopists using 11 endoscopic images captured during endoscopy.</measure>
    <time_frame>through study completion, an average of 3 months</time_frame>
    <description>&quot;Visibility score&quot; (0-25 points) counted as the sum of visibility score in the esophagus (0-5), fundus (0-5), corpus (0-5) and atrum (0-5) of the stomach and in the duodenum (0-5).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual fluid in the stomach evaluated by blinded performing endoscopist</measure>
    <time_frame>through study completion, an average of 3 months</time_frame>
    <description>0-3 point scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of endoscopy</measure>
    <time_frame>through study completion, an average of 3 months</time_frame>
    <description>time between introduction and withdrawal of the endoscopy</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Gastroscopy; Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>A - mucolytic solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mucolytic solution consisting of 100 ml of water, 100 mg of simethicon and 400 mg of N-acetylcystein administered 30 minutes prior to upper endoscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B - no intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Upper endoscopy without neither mucolytic solution nor water prior to upper endoscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C - water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>100 ml of water given 30 minutes prior to upper endoscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Administration of mucolytic solution before upper endoscopy (Espumisan, ACC long)</intervention_name>
    <arm_group_label>A - mucolytic solution</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Administration of water before upper endoscopy</intervention_name>
    <arm_group_label>C - water</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 years

          -  signed informed consent

          -  diagnostic gastroscopy

        Exclusion Criteria:

          -  age &lt; 18 years

          -  interventional gastroscopy

          -  known disease of the upper GI tract and/or history of surgery of GI tract

          -  gastroscopy indicated of bleeding, dysphagia or ileus

          -  liver cirrhosis

          -  general anesthesia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Premysl Falt, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Digestive Diseases Center, VÃ­tkovice Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Premysl Falt, M.D., Ph.D.</last_name>
    <phone>+420595633</phone>
    <phone_ext>205</phone_ext>
    <email>faltprem@centrum.cz</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Barbora Pipek, M.D.</last_name>
    <phone>+420595633</phone>
    <phone_ext>205</phone_ext>
    <email>barbora.pipek@seznam.cz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Digestive Diseases Center</name>
      <address>
        <city>Ostrava</city>
        <zip>70384</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Premysl Falt, M.D., Ph.D.</last_name>
      <phone>+420602689561</phone>
      <email>faltprem@centrum.cz</email>
    </contact>
  </location>
  <location_countries>
    <country>Czech Republic</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2016</study_first_submitted>
  <study_first_submitted_qc>November 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2016</study_first_posted>
  <last_update_submitted>November 27, 2016</last_update_submitted>
  <last_update_submitted_qc>November 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vitkovice Hospital</investigator_affiliation>
    <investigator_full_name>Premysl Falt, M.D., Ph.D.</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Expectorants</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

